tm logo
NOVELSTAR
Live/Registered
REGISTERED

on 04 Jan 2022

Last Applicant/ Owned by

2005 Eastpark Blvd

Cranbury

NJ

08512

Serial Number

88016687 filed on 27th Jun 2018

Registration Number

6604680 registered on 04th Jan 2022

in the Principal Register

Correspondent Address

Michael J. Leonard

Michael J. Leonard

997 Lenox Drive, Bldg. 3

Lawrenceville, NJ, 08648-2311

Filing Basis

1. intent to use

Disclaimer

NO DATA

NOVELSTAR

Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes

Mark Details


Serial Number

No 88016687

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 186181.00002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Jan 2022REGISTERED-PRINCIPAL REGISTER
19th Oct 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19th Oct 2021PUBLISHED FOR OPPOSITION
29th Sep 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10th Sep 2021NOTICE OF ALLOWANCE CANCELLED
01st Sep 2021ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
01st Sep 2021PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
30th Aug 2021ASSIGNED TO PETITION STAFF
27th Aug 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th Aug 2021EXTENSION 4 GRANTED